Drugs

Generic Drugs Guidances & Reports

The research studies conducted under Generic Drug User Fee Amendments (GDUFA) initiatives support development of general and product-specific guidances for industry to efficiently develop new generic products. OGD also publishes an annual research report each fiscal year, summarizing the research activities and outcomes from both extramural and intramural projects.

Notable Guidances Related to GDUFA-funded Regulatory Science Projects
Recent product-specific recommendations for complex products developed as a result of regulatory science projects:

Regulatory Science Research Reports
These annual reports describe the activities and progress in each of five regulatory science priority areas.

 

Page Last Updated: 02/16/2018
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English